Subscribe
Monday, September 14, 2026
26.9 C
Bengaluru
type here...
Subscribe
Featured ArticleHealthcare News
3 min.Read

Creador Bets Big on Indian Pharma with 7% La Renon Stake

Anup Soans
By Anup Soans

In a significant development for the Indian pharmaceutical industry, Kuala Lumpur-based private equity firm Creador has acquired a 7% stake in Ahmedabad-headquartered La Renon Healthcare for ₹800 crore. This investment values La Renon at nearly ₹11,000 crore, marking a major milestone in the company’s rapid growth journey and reflecting robust investor confidence in India’s pharmaceutical…

Free Membership Required

You must be a Free member to access this content.

Join Now

Already a member? Log in here

Hot this week

Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...

Topics

Digital in Pharma

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...
Featured Article

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...
Healthcare Ececutive

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...
Featured Article

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...
MedicinMan Pharma Pulse

MedicinMan Pharma Pulse: August 2026

0
🚀 The Mega-Merger That Wasn't Early August saw the...
Featured Article

GLP-1: When the Molecule Becomes a Commodity, What Becomes the Moat?

0
STOP PRESS August 10, 2026: Regulatory Authorisation — The UK...
Exclusive Report

How To See Dr Reddy’s Nestle In The Wellness Shift

0
GLP-1 medicines such as semaglutide and tirzepatide are changing...
The Pharma Executive

How To Power The India Biopharma Regulatory Revolution Now

0
Beyond the Pharmacy of the World: Why India's Biopharma...
spot_img

Related Articles

spot_imgspot_img
Previous article
Novo Nordisk’s Big Reset: What 9,000 Job Cuts Signal for Pharma’s Future
Next article
India’s Patent Revocations: Strengthening Access and Challenging Evergreening

MedicinMan was launched in 2011 as India’s 1st Magazine dedicated to the cause of Field Force Excellence in Pharma and Devices.
Read More

Company

Headlines

The Great Healthcare Pivot: Who Owns The Consumer Before They Become A Patient?

0
How wearables, diagnostics, AI and continuous monitoring are moving...

RPG-Raghava and Lessons From a Decade of Indian Pharma M&A

0
RPG Active Pharma’s agreement to acquire the API and...

Pharmacy of the World Pricing Paradox

0
India occupies an extraordinary position in global pharmaceuticals. It...

Why The Government Must Stop Playing Market Trader And Start Being The Sheriff

0
India has two very different pharmaceutical regulators living inside...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 | Crafted by SlamDunk